CancerNetwork Members: Login | Register
Become a fan on Facebook  Add us on Google Plus Follow us on Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » ASCO 2011 » ASCO Breast Cancer 2011

CONFERENCE REPORT 

ASCO 2011: Dr. Luca Gianni Discusses New Research and His Work on HER2+ Breast Cancer

Interviewed by the editors of ONCOLOGY | June 13, 2011

Dr. Luca Gianni, director of medical oncology and coordinator of the New Treatments' Development Programme at the Istituto Nazionale Tumori, Milano, Italyand the 2011 recipient of the Gianni Bonadonna Breast Cancer Award for his achievements in advancing the field of breast cancer research.

Dr. Gianni has been involved with new drug therapies in medical oncology for some time, and in this interview he discusses the changing use of breast cancer treatments, neoadjuvant regimens, and research and developments on HER2+ breast cancer.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
ASCO 2011

ASCO 2011: Cytoreductive Surgery plus HIPEC for Metastatic Colon Cancer
October 3, 2011
ASCO 2011: Ramaswami Govindan Discusses Current and Upcoming Lung Cancer Research
August 29, 2011
ASCO 2011: Dr. Antoni Ribas Discusses the Impact of 2 New Drugs for the Treatment of Metastatic Melanoma
August 19, 2011
ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials
August 12, 2011
ASCO 2011: Nancy Dawson Discusses Screening for PSA in Prostate Cancer
August 5, 2011
 
TOPIC INDEX

Cancer Types

  
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics
  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter



CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy